EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Role of Necroptosis and Neuroinflammation in CSVD ‐Associated Cognitive Decline in db/db Mice

Dan-Qiong Wang, Lei Wang, Ping Zhao, Yu-Meng Gu, Xiao-Shuang Xia, Tao Li, Na An, Xin Li iD

The FASEB Journal · 2025

DOI: 10.1096/fj.202500772r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Dan-Qiong Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Medicine, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Sh…. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Necroptosis, Neuroinflammatory Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes‐related cerebral small‐vessel disease (CSVD) is an important causative factor of cognitive impairment, but its molecular mechanisms have not been clarified. The aim of this study was to investigate the role of the necrotic apoptotic pathway (RIP1/RIP3/MLKL) and the inflammatory response in diabetic CSVD. Wild‐type C57BL/6 mice and leptin receptor‐deficient db/db mice were categorized into six groups according to age (8‐, 12‐, and 16‐week time points) and genotype. Cognitive function was assessed by the water maze experiment (escape latency, percentage of time spent in the target quadrant, and number of times through the table); cerebral atrophy and ventricular dilatation were detected by cranial MRI; cerebral microvascular structure, cortical neuronal damage, and ultrapathological changes in hippocampal mitochondria were observed by HE staining and transmission electron microscopy, respectively; and blood–brain barrier‐associated proteins were detected by western blot and RT‐qPCR (occludin, ZO‐1, VEGFA) and necroptotic apoptotic pathway molecules (RIP1, RIP3, MLKL). Western blot and RT‐qPCR were used to detect the protein and mRNA expression of blood–brain barrier‐associated proteins (occludin, ZO‐1, VEGFA) and necroptotic apoptotic pathway molecules (RIP1, RIP3, MLKL). Immunohistochemistry was used to localize the distribution of RIP1/RIP3/MLKL in the brain tissues; and plasma levels of inflammatory factors (IL‐6, IL‐10, TNF‐α, NF‐κB) were quantified by ELISA. In db/db mice: (1) spatial learning and memory abilities were reduced compared to wild‐type (WT) mice; (2) at 16 weeks of age, db/db mice showed signs of temporal lobe atrophy and an enlarged fourth cerebral ventricle; (3) capillary proliferation and cortical injury were observed in the frontal cortex, along with mitochondrial swelling, degeneration, and nuclear membrane rupture in hippocampal cells; (4) the occludin and ZO‐1 protein expression in the db/db‐16W group decreased to 0.48‐ and 0.68‐fold of the WT‐8W group, respectively, and the VEGFA was elevated by 2.87‐fold; the mRNA expression of RIP1/RIP3/MLKL was up‐regulated to 3.02‐, 3.12‐, and 4.02‐fold of the WT group, the relative expression of western blot proteins increased synchronously; the increase in the number of immunohistochemically positive cells increased synchronously, and (5) plasma inflammatory factors were significantly elevated in db/db mice: IL‐6 ↑3.81‐fold, TNF‐α ↑4.23‐fold, NF‐κB ↑3.56‐fold. This study reveals for the first time the molecular mechanism by which diabetes drives cerebral small vessel disease (CSVD) through the spatiotemporal‐dependent activation of the necrotic apoptotic pathway (RIP1/RIP3/MLKL), and targeting the necrotic apoptotic pathway may serve as a potential therapeutic strategy for diabetes‐associated cognitive deficits by concurrently protecting the blood–brain barrier and suppressing neuroinflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionNecroptosisNeuroinflammatory DiseasesAnimalsMiceMice, Inbred C57BLMaleHippocampusReceptor-Interacting Protein Serine-Threonine KinasesApoptosisProtein KinasesInflammationBlood-Brain BarrierGTPase-Activating Proteins

Stichwörter der Autor:innen

cerebral small vessel disease (CSVD)cognitive impairmentdiabetes mellitusinflammationnecroptosis

Substanzen

Ralbp1 protein, mouseReceptor-Interacting Protein Serine-Threonine KinasesProtein KinasesGTPase-Activating Proteins

Autor:innen und Institutionen

  • Department of Geriatric Medicine, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, China.
  • Department of Neurology, The Second Hospital of Tianjin Medical University, Tianjin, China.

ORCID-Profile: Xin Li

Zitieren

APA

Wang, D. Q., Wang, L., Zhao, P., Gu, Y. M., Xia, X. S., Li, T., An, N., & Li, X. (2025). Role of Necroptosis and Neuroinflammation in CSVD ‐Associated Cognitive Decline in db/db Mice. The FASEB Journal. https://doi.org/10.1096/fj.202500772r

Vancouver

Wang DQ, Wang L, Zhao P, Gu YM, Xia XS, Li T, et al. Role of Necroptosis and Neuroinflammation in CSVD ‐Associated Cognitive Decline in db/db Mice. The FASEB Journal. 2025. doi:10.1096/fj.202500772r

BibTeX
@article{Wang2025,
  author = {Wang, Dan-Qiong and Wang, Lei and Zhao, Ping and Gu, Yu-Meng and Xia, Xiao-Shuang and Li, Tao and An, Na and Li, Xin},
  title = {Role of Necroptosis and Neuroinflammation in CSVD ‐Associated Cognitive Decline in db/db Mice},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202500772r}
}
Kostenlos starten →